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Microbiology SelectThis issue’s Microbiology Select describes recent insights into the mechanisms and consequences of viral infections,
including a functional genomics screen that reports an array of previously unknown host factors required for HIV-1
infection of cultured human cells. New work also defines host factors that restrain the release of HIV-1 from cells and
reveals how a class of antimicrobial peptides inhibits adenoviral infections. Other discoveries include a protein in
mitochondria that modulates antiviral signaling, and evidence that a rare but dangerous form of skin cancer may have
a viral origin.
Capturing HIV’s Cellular Accomplices
The human immunodeficiency virus (HIV) genome encodes a relatively meager 15
proteins and hence must rely on guile or the unknowing complicity of the host to
make its way in the complex world of the host cell. Although multiple host factors
have been previously implicated in individual steps of the HIV life cycle (for example
cell entry, transit to the nucleus, DNA integration, replication, and budding), the recent
efforts by Brass et al. (2008) provide a holistic view of HIV infection that is unprece-
dented in its scope. They harnessed the power of RNA interference to systematically
screen for factors in the host cell that facilitate HIV infection. By conducting a large-
scale screen of small interfering RNAs (siRNAs) in HeLa cells in vitro, they identify
more than 250 human proteins that are needed for HIV-1 infection. This effort reveals
in an unbiased fashion the cellular processes that the virus commandeers in its quest
to replicate and spread, including the identification of many pathways and macromo-
lecular complexes not previously implicated in HIV-1 infection. For example, the au-
thors show that retrograde Golgi transport is involved in viral entry and that the huge
Mediator complex facilitates viral transcription. Other surprises include the discovery
that proteins involved in autophagy are also involved in the HIV life cycle, a connection
that future work may delve into further. This work also opens the door to identifying
host factors, rather than factors encoded by the virus, that might be targeted to quell
HIV infection. Future efforts might determine combinations of siRNAs—simulta-
neously targeting multiple steps of the viral life cycle—that provide the greatest inhi-
bition of viral spread while minimizing deleterious effects on the host cell.
A.L. Brass et al. (2008). Science. Published online January 10, 2008. 10.1126/science.1152725.
The Ties That Bind a Virus to the Cell
Previous work has shown that HIV-1 requires an accessory protein Vpu to promote
the release of virus from the surface of infected cells. HIV-1 virions from strains lacking
Vpu are not shed readily and instead accumulate at the cell surface. Neil et al. (2008)
now report the identification of a host cell surface protein, which the authors call
Tetherin (also known as CD317), that restrains the release of HIV-1 from cells and
is the target of Vpu. Building on their previous observation that in some cell types
the inhibition of virion release is induced by the cytokine interferon-a, the authors
usedmicroarray analysis to identify mRNAs that are upregulated in multiple cell types
in response to exposure to interferon-a. This screen identified a number of cell sur-
face proteins, including CD317, a protein with no previously characterized function.
Transgenic expression of the gene encoding CD317 was sufficient to inhibit the
release of virions lacking Vpu in two cultured cell lines that normally do not display
the capacity to effectively tether virions in the absence of stimulation by interferon-
a. Similar results were obtained in experiments using murine leukemia virus instead
of HIV-1. Hence, CD317 may have broad antiviral activity against enveloped viruses
and may be part of a larger innate immune response to enveloped viruses initiated
by interferon-a. In this regard, it may be fruitful to explore whether other cell surface
proteins induced by interferon-a have tethering activity against different classes of
viruses. Future work may also explore the mechanism by which CD317 inhibits virion
release or how its activity is countered by Vpu.
S.J.D. Neil et al. (2008). Nature. Published online January 16, 2008. 10.1038/nature06553.
Treatment with siRNAs targeting trans-
portin 3 reduces levels of HIV-1 (red) in
infected HeLa cells (right) compared to
cells treated with negative control siRNAs
(left). Images courtesy of A. Brass.
Electron micrograph showing nascent
HIV-1 particles unable to escape the sur-
face of an infected cell due to the action
of an innate antiviral molecule called
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Defensins Take Aim at Viral Intruders
Antimicrobial peptides provide an important first layer of defense against would-
be invaders. One class of peptideswithwell-characterized antibacterial activity is
thatof thedefensins.However, emerging evidencesuggests that somedefensins
may also have antiviral properties.Given that defensins are thought to target bac-
teria in part by forming pores in their membranes, it has been difficult to envision
the mechanism by which they would inhibit infection by viruses that lack a mem-
brane envelope, such as adenovirus. In their new work, Smith and Nemerow
(2008) confirm the antiviral properties of human a-defensins against adenovirus
anddetermine theirmechanismofaction. Theauthors show that twoa-defensins,
humanneutrophil peptide-1 (HNP1) andhumandefensin-5 (HD5), inhibit infection
by human adenovirus at micromolar concentrations. They then show that HD5
blocks viral penetration of the endosome in the host cell, a key step early in the
virus life cycle. To accomplish this, HD5 binds directly to the viral capsid and pre-
vents uncoating of the virus. This work suggests that small molecules that mimic
the effect of a-defensins might have therapeutic potential. Structural insight into
the HD5-capsid interaction might hold great value for future efforts in developing
antiviral drugs.
J.G. Smith and G.R. Nemerow (2008). Cell Host Microbe 3, 11–19.
Putting the Kibosh on Mitochondrial Antiviral Signaling
TheNLR family of proteinsplays critical roles in the innate immune response. Tobetter un-
derstand thepotential roleofNLRproteins in theantiviral signalingmediatedbymitochon-
dria,Moore et al. (2008) used a bioinformatic approach to identify NLRproteins thatmight
localize to mitochondria. They found one candidate, NLRX1, which has a mitochondrial
targeting sequence and confirmed that it localizes to the mitochondrial outer membrane.
Surprisingly, they discover that NLRX1 dampens rather than enhances antiviral signaling.
Instead, NLRX1 binds to the mitochondrial antiviral signaling adaptor MAVS and inhibits
the activation of MAVS by RIG-I-like RNA helicases, which are sensors for intracellular
double-stranded RNA. The loss of MAVS activation due to NLRX1 inhibits downstream
signaling and reduces the production of the cytokine interferon-b. Consequently, target-
ingNLRX1 using small interfering RNA enhances the production of interferon-b in human
embryonic kidney 293Tcells infectedwith theSendai virus and a similar treatment inhibits
the replication of Sindbis virus. These findings pinpoint NLRX1 as a prime target for future
efforts to establish new therapies to enhance cellular responses to viral infections.
C.B. Moore et al. (2008). Nature. Published online January 16, 2008. 10.1038/
nature06501.
An Integrated View of Merkel Cell Carcinoma
Merkel cell carcinoma is a rare form of skin cancer that arises fromMerkel cells, which are me-
chanotransducing cells in the skin involved in the sense of touch. Although the causes of Mer-
kel cell carcinoma are unknown, it has been speculated that its origin could involve an infec-
tious agent, given that it occurs more frequently in immunosuppressed individuals. Recent
findings by Feng et al. (2008) now suggest that the root cause for many cases of humanMerkel
cell carcinoma is a newly discovered polyomavirus. The authors used an approach called dig-
ital transcriptome subtraction that involves high throughput sequencing of cDNAs from tumors
of patients with Merkel cell carcinoma to identify sequences of viral origin. They discovered
that a previously unknown virus, which the authors named Merkel cell polyomavirus (MCV),
is detectable in 80% of the tumors analyzed but is found in only 16%of skin samples from con-
trol individuals. In most cases, MCV had integrated into the genome prior to the clonal expan-
sion of the tumor, providing support for the notion that its presence contributes to tumor for-
mation rather than being coincidental. Although it is not yet clear how MCV might promote
tumorigenesis, the authors propose that it could involve either insertional mutagenesis or ex-
pression of the MCV homologue of the SV40 large T antigen, which has the demonstrated ca-
pacity to transform multiple cell types. This approach may now be applied to the identification
of other currently unknown viruses that may lurk in the shadows of human cancer.
H. Feng et al. (2008). Science. Published online January 17, 2008. 10.1126/science.1152586.
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An image reconstruction of a virus-infected
A549 cell shows that adenovirus (red) accumu-
lates in lysosomes (beige) in the presence of the
defensin HD5; nucleus (blue). Image courtesy
of J. Smith.
Colorized transmission electron mi-
crograph of a single mitochondria
showing the mitochondrial mem-
brane localization of NLRX1. Image
courtesy of C. Moore.
Mitotic figures are prominent
in Merkel cell carcinoma, an
aggressive neuroectodermal
tumor; tissue section stained
with hematoxylin and eosin.
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